| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.28 | 8e-05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.003 |